{"id":440,"date":"2026-02-26T09:00:00","date_gmt":"2026-02-26T09:00:00","guid":{"rendered":"https:\/\/all-cancers.com\/cancer\/myeloproliferative-neoplasms-mpns-cancer\/"},"modified":"2026-02-26T09:00:00","modified_gmt":"2026-02-26T09:00:00","slug":"myeloproliferative-neoplasms-mpns-cancer","status":"publish","type":"cancer_type","link":"https:\/\/all-cancers.com\/zh-hk\/cancer\/myeloproliferative-neoplasms-mpns-cancer\/","title":{"rendered":"\u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624 (MPN)"},"content":{"rendered":"<div class=\"ac-blog-article\">\n<p class=\"ac-blog-lead\"><strong>\u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624\uff08MPN\uff09\u662f\u6307\u4e00\u7d44\u4ee5\u9aa8\u9ad3\u5167\u8840\u7403\u904e\u5ea6\u751f\u6210\u70ba\u7279\u5fb5\u7684\u8840\u764c\u3002\u9019\u4e9b\u75be\u75c5\u5f71\u97ff\u91cd\u8981\u7684\u7d30\u80de\u8b5c\u7cfb\uff0c\u5305\u62ec\u767d\u8840\u7403\u3001\u7d05\u8840\u7403\u548c\u8840\u5c0f\u677f\uff0c\u7834\u58de\u6b63\u5e38\u7684\u8840\u6db2\u5e73\u8861\u548c\u529f\u80fd\u3002\u5f9e\u672c\u8cea\u4e0a\u8b1b\uff0cMPN \u662f\u7531\u5c0e\u81f4\u7d30\u80de\u589e\u6b96\u5931\u63a7\u7684\u57fa\u56e0\u7a81\u8b8a\u5f15\u8d77\u7684\u3002<\/strong><\/p>\n<nav class=\"ac-blog-toc\" aria-label=\"\u672c\u6587\u5c0e\u89bd\">\n<p><strong>\u672c\u6587\u5c0e\u89bd<\/strong><\/p>\n<ul>\n<li><a href=\"#what-is-myeloproliferative-neoplasms-mpns\">\u4ec0\u9ebc\u662f\u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624 (MPN)\uff1f<\/a><\/li>\n<li><a href=\"#causes-and-risk-factors-of-myeloproliferative-neoplasms-mpns\">\u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624 (MPN) \u7684\u75c5\u56e0\u548c\u5371\u96aa\u56e0\u5b50<\/a><\/li>\n<li><a href=\"#symptoms-of-myeloproliferative-neoplasms-mpns\">\u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624 (MPN) \u7684\u75c7\u72c0<\/a><\/li>\n<li><a href=\"#stages-of-myeloproliferative-neoplasms-mpns-and-survival-rates\">\u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624 (MPN) \u7684\u5206\u671f\u548c\u5b58\u6d3b\u7387<\/a><\/li>\n<li><a href=\"#treatment-options-for-myeloproliferative-neoplasms-mpns\">\u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624 (MPN) \u7684\u6cbb\u7642\u9078\u64c7<\/a><\/li>\n<li><a href=\"#limitations-of-traditional-therapies-for-myeloproliferative-neoplasms-mpns\">\u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624 (MPN) \u50b3\u7d71\u7642\u6cd5\u7684\u5c40\u9650\u6027<\/a><\/li>\n<\/ul>\n<\/nav>\n<h2 id=\"what-is-myeloproliferative-neoplasms-mpns\">\u4ec0\u9ebc\u662f <strong>\u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624 (MPN)<\/strong>?<\/h2>\n<p>\u5728\u764c\u75c7\u751f\u7269\u5b78\u9818\u57df\uff0c\u4eba\u5011\u5c0d\u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624 (MPN) \u7684\u8a8d\u8b58\u6709\u4e86\u986f\u8457\u767c\u5c55\uff0c\u91cd\u9ede\u95dc\u6ce8\u7d30\u80de\u4ee3\u8b1d\u7570\u5e38\u3002\u74e6\u4f2f\u683c\u6548\u61c9\u662f\u5305\u62ec MPN \u5728\u5167\u7684\u8a31\u591a\u764c\u75c7\u7684\u4e00\u500b\u6a19\u8a8c\uff0c\u9019\u662f\u4e00\u7a2e\u4ee3\u8b1d\u73fe\u8c61\uff0c\u764c\u7d30\u80de\u6d88\u8017\u8461\u8404\u7cd6\u7684\u901f\u5ea6\u6bd4\u5065\u5eb7\u7d30\u80de\u5feb 200 \u500d\u3002\u9019\u7a2e\u904e\u91cf\u7684\u8461\u8404\u7cd6\u6d88\u8017\u63d0\u4f9b\u4e86\u5feb\u901f\u7684\u80fd\u91cf\uff0c\u4fc3\u9032\u4e86\u764c\u7d30\u80de\u5feb\u901f\u4e14\u4e0d\u53d7\u63a7\u5236\u7684\u751f\u9577\u3002<\/p>\n<h3 id=\"biological-basis-behind-myeloproliferative-neoplasms-mpns\">\u80cc\u5f8c\u7684\u751f\u7269\u5b78\u57fa\u790e <strong>\u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624 (MPN)<\/strong><\/h3>\n<p>MPN \u6e90\u81ea\u65bc\u4e3b\u8981\u5f71\u97ff\u9aa8\u9ad3\u4e2d\u9020\u8840\u5e79\u7d30\u80de\u7684\u7a81\u8b8a\u3002\u4e00\u4e9b\u5df2\u78ba\u5b9a\u7684\u57fa\u56e0\u7a81\u8b8a\uff0c\u7279\u5225\u662f JAK2\u3001CALR \u548c MPL\uff0c\u5c0d MPN \u767c\u75c5\u6a5f\u5236\u6709\u986f\u8457\u5f71\u97ff\u3002\u5176\u4e2d\uff0cJAK2 V617F \u7a81\u8b8a\u6700\u70ba\u5e38\u898b\uff0c\u7d04 50-60% \u7684\u539f\u767c\u6027\u8840\u5c0f\u677f\u589e\u591a\u75c7 (ET) \u548c\u539f\u767c\u6027\u9aa8\u9ad3\u7e96\u7dad\u5316 (PMF) \u60a3\u8005\u4ee5\u53ca\u8d85\u904e 90% \u7684\u771f\u6027\u7d05\u8840\u7403\u589e\u591a\u75c7 (PV) \u75c5\u4f8b\u4e2d\u767c\u73fe\u8a72\u7a81\u8b8a\u3002\u9019\u4e9b\u7a81\u8b8a\u6703\u6d3b\u5316\u8a0a\u865f\u901a\u8def\uff0c\u4fc3\u9032\u8840\u7403\u589e\u751f\u3001\u7d05\u8840\u7403\u589e\u591a\u548c\u8840\u5c0f\u677f\u589e\u591a\uff0c\u5f15\u767c\u75be\u75c5\u7684\u767c\u751f\u548c\u9032\u5c55\u3002<\/p>\n<p>\u6b64\u5916\uff0c\u764c\u7d30\u80de\uff0c\u5305\u62ec MPN \u4e2d\u7684\u764c\u7d30\u80de\uff0c\u8868\u73fe\u51fa\u8d85\u51fa Warburg \u6548\u61c9\u7684\u7279\u6b8a\u4ee3\u8b1d\u8106\u5f31\u6027\u3002\u5b83\u5011\u56b4\u91cd\u4f9d\u8cf4\u9ea9\u91af\u80fa\u9178\u4ee3\u8b1d\uff0c\u9ea9\u91af\u80fa\u9178\u4ee3\u8b1d\u5c0d\u65bc\u7522\u751f\u5feb\u901f\u7d30\u80de\u8907\u88fd\u6240\u9700\u7684\u5927\u91cf\u5efa\u69cb\u6a21\u7d44\uff08\u5982\u6838\u82f7\u9178\u548c\u80fa\u57fa\u9178\uff09\u81f3\u95dc\u91cd\u8981\u3002\u9019\u7a2e\u4f9d\u8cf4\u6027\u70ba\u6a19\u9776\u4ee3\u8b1d\u7642\u6cd5\u63d0\u4f9b\u4e86\u5275\u65b0\u6a5f\u6703\uff0c\u6539\u8b8a\u4e86\u764c\u75c7\u7ba1\u7406\u7684\u53ef\u80fd\u6027\u3002<\/p>\n<h3 id=\"prevalence-and-impact-of-myeloproliferative-neoplasms-mpns-particularly-in-hong-\">\u6d41\u884c\u7387\u548c\u5f71\u97ff <strong>\u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624 (MPN)<\/strong>\uff0c\u7279\u5225\u662f\u5728\u9999\u6e2f\u548c\u4e9e\u6d32<\/h3>\n<p>\u5728\u5168\u7403\u7bc4\u570d\u5167\uff0cMPN \u76f8\u5c0d\u7f55\u898b\uff0c\u4f46\u5176\u767c\u75c5\u7387\u6b63\u5728\u589e\u52a0\uff0c\u9019\u4e3b\u8981\u662f\u7531\u65bc\u66f4\u597d\u7684\u8a3a\u65b7\u65b9\u6cd5\u548c\u4eba\u53e3\u8001\u5316\u3002\u6bcf\u5e74\uff0c\u5168\u4e16\u754c\u6bcf 10 \u842c\u4eba\u4e2d\u7d04\u6709 2.5-3 \u4f8b MPN \u88ab\u8a3a\u65b7\u51fa\u4f86\uff0c\u5373\u6bcf\u5e74\u6709\u6578\u5343\u4f8b\u75c5\u4f8b\u3002\u5728\u4e9e\u6d32\uff0c\u5c24\u5176\u662f\u9999\u6e2f\uff0cMPN \u75c5\u4f8b\u5448\u73fe\u7a69\u5b9a\u8da8\u52e2\uff0c\u8207\u5168\u7403\u767c\u75c5\u7387\u57fa\u672c\u4e00\u81f4\uff0c\u4e3b\u8981\u5f71\u97ff 50 \u6b72\u6216\u4ee5\u4e0a\u7684\u8001\u5e74\u4eba\u3002\u67d0\u4e9b\u4e9e\u578b\uff0c\u5982\u539f\u767c\u6027\u8840\u5c0f\u677f\u589e\u591a\u75c7\u548c\u539f\u767c\u6027\u9aa8\u9ad3\u7e96\u7dad\u5316\uff0c\u5728\u4e9e\u6d32\u8001\u5e74\u4eba\u53e3\u4e2d\u7684\u767c\u751f\u7387\u9032\u4e00\u6b65\u5347\u9ad8\uff0c\u51f8\u986f\u4e86\u5340\u57df\u91ab\u7642\u7b56\u7565\u7684\u8feb\u5207\u9700\u6c42\u3002<\/p>\n<ul>\n<li>MPN \u8a3a\u65b7\u7684\u4e2d\u4f4d\u6578\u5e74\u9f61\u7d04\u70ba 60-65 \u6b72\u3002<\/li>\n<li>\u96d6\u7136\u7537\u6027\u548c\u5973\u6027\u90fd\u9762\u81e8 MPN \u98a8\u96aa\uff0c\u4f46\u539f\u767c\u6027\u8840\u5c0f\u677f\u589e\u591a\u75c7\u7a0d\u5fae\u504f\u5411\u5973\u6027\u60a3\u8005\u3002<\/li>\n<li>\u5728\u9999\u6e2f\uff0c\u8207\u897f\u65b9\u4eba\u53e3\u76f8\u6bd4\uff0c\u63a5\u89f8\u7279\u5b9a\u74b0\u5883\u56e0\u7d20\uff08\u4f8b\u5982\u6c61\u67d3\u3001\u751f\u6d3b\u65b9\u5f0f\u5f71\u97ff\u548c\u98f2\u98df\u7fd2\u6163\uff09\u53ef\u80fd\u6703\u7522\u751f\u4ea4\u53c9\uff0c\u5c0e\u81f4\u7576\u5730\u6d41\u884c\u75c5\u5b78\u7565\u6709\u4e0d\u540c\u3002<\/li>\n<\/ul>\n<p>\u5f9e\u66f4\u5ee3\u6cdb\u7684\u6d41\u884c\u75c5\u5b78\u89d2\u5ea6\u4e86\u89e3\u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624\uff08MPN\uff09\u6709\u52a9\u65bc\u91ab\u5b78\u5c08\u5bb6\u88fd\u5b9a\u5177\u9ad4\u7684\u7be9\u6aa2\u548c\u7ba1\u7406\u8a08\u5283\uff0c\u512a\u5316\u60a3\u8005\u9810\u5f8c\u548c\u751f\u6d3b\u54c1\u8cea\u3002<\/p>\n<h3 id=\"physical-and-emotional-impact-of-myeloproliferative-neoplasms-mpns\">\u5c0d\u8eab\u9ad4\u548c\u60c5\u7dd2\u7684\u5f71\u97ff <strong>\u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624 (MPN)<\/strong><\/h3>\n<p>\u60a3\u6709 MPN \u901a\u5e38\u610f\u5473\u8457\u8981\u61c9\u5c0d\u8907\u96dc\u7684\u8eab\u9ad4\u75c7\u72c0\uff0c\u5982\u75b2\u52de\u3001\u813e\u816b\u5927\u3001\u9ad4\u91cd\u6e1b\u8f15\u3001\u76dc\u6c57\u548c\u9aa8\u75db\u3002\u9019\u4e9b\u75c7\u72c0\u56b4\u91cd\u640d\u5bb3\u751f\u6d3b\u54c1\u8cea\u3001\u65e5\u5e38\u529f\u80fd\u548c\u6574\u9ad4\u5065\u5eb7\u3002\u540c\u6642\uff0c\u764c\u75c7\u8a3a\u65b7\u5e36\u4f86\u7684\u60c5\u7dd2\u58d3\u529b\u6703\u5c0d\u60a3\u8005\u7522\u751f\u6df1\u9060\u7684\u5f71\u97ff\uff0c\u5f15\u767c\u7126\u616e\u3001\u6182\u9b31\u548c\u5b64\u7acb\u611f\u3002<\/p>\n<p>\u5728 AllCancer\uff0c\u6211\u5011\u77e5\u9053\u7d9c\u5408\u6cbb\u7642\u6d89\u53ca\u89e3\u6c7a\u5fc3\u7406\u793e\u6703\u554f\u984c\uff0c\u800c\u4e0d\u50c5\u50c5\u662f\u8eab\u9ad4\u75c7\u72c0\u3002\u6211\u5011\u7684\u65b9\u6cd5\u78ba\u4fdd\u500b\u4eba\u5316\u3001\u5bcc\u6709\u540c\u60c5\u5fc3\u7684\u8b77\u7406\uff0c\u4ee5\u589e\u5f37\u61c9\u5c0d\u7b56\u7565\u548c\u60a3\u8005\u8ce6\u6b0a\uff0c\u5275\u9020\u7a4d\u6975\u7684\u5065\u5eb7\u8ecc\u8de1\u3002<\/p>\n<h2 id=\"causes-and-risk-factors-of-myeloproliferative-neoplasms-mpns\">\u539f\u56e0\u548c\u5371\u96aa\u56e0\u7d20 <strong>\u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624 (MPN)<\/strong><\/h2>\n<h3 id=\"genetic-risk-factors\">\u907a\u50b3\u98a8\u96aa\u56e0\u7d20<\/h3>\n<p>\u4e00\u4e9b\u57fa\u56e0\u7a81\u53d8\u4f7f\u4e2a\u4f53\u6613\u60a3 MPN\u3002 JAK2 \u7a81\u8b8a\u6700\u70ba\u5e38\u898b\uff0c\u4f46 CALR \u548c MPL \u57fa\u56e0\u7a81\u8b8a\u4e5f\u5e38\u51fa\u73fe\u3002\u9019\u4e9b\u57fa\u56e0\u7570\u5e38\u6703\u89f8\u767c JAK-STAT \u8a0a\u865f\u901a\u8def\u7684\u7570\u5e38\u6fc0\u6d3b\uff0c\u5c0e\u81f4\u8840\u7403\u751f\u9577\u5931\u63a7\u3002\u9019\u4e9b\u7a81\u8b8a\u7684\u65e9\u671f\u8b58\u5225\u986f\u8457\u6539\u5584\u4e86\u60a3\u8005\u76e3\u6e2c\u548c\u6cbb\u7642\u65b9\u6cd5\u3002<\/p>\n<ul>\n<li>JAK2 V617F \u7a81\u8b8a\u5728\u771f\u6027\u7d05\u8840\u7403\u589e\u591a\u75c7\u4e2d\u666e\u904d\u5b58\u5728\uff08\u767c\u751f\u7387 &gt;95%\uff09\u3002<\/li>\n<li>CALR \u7a81\u8b8a\u4e3b\u8981\u898b\u65bc\u7121 JAK2 \u7a81\u8b8a\u7684\u539f\u767c\u6027\u8840\u5c0f\u677f\u589e\u591a\u75c7\u53ca\u539f\u767c\u6027\u9aa8\u9ad3\u7e96\u7dad\u5316\u60a3\u8005\u3002<\/li>\n<li>MPL \u7a81\u8b8a\u76f8\u5c0d\u7f55\u898b\uff0c\u4f46\u5c0d\u65bc\u8a3a\u65b7\u9451\u5225\u548c\u6cbb\u7642\u6c7a\u7b56\u5177\u6709\u91cd\u8981\u610f\u7fa9\u3002<\/li>\n<\/ul>\n<h3 id=\"environmental-and-lifestyle-factors\">\u74b0\u5883\u548c\u751f\u6d3b\u65b9\u5f0f\u56e0\u7d20<\/h3>\n<p>\u5118\u7ba1\u5f88\u5927\u7a0b\u5ea6\u4e0a\u662f\u907a\u50b3\u9a45\u52d5\u7684\uff0c\u4f46\u74b0\u5883\u548c\u751f\u6d3b\u65b9\u5f0f\u56e0\u7d20\u53ef\u80fd\u6703\u900f\u904e\u7d2f\u7a4d\u66b4\u9732\u65bc\u5404\u7a2e\u58d3\u529b\u6e90\u800c\u9593\u63a5\u5c0e\u81f4 MPN \u98a8\u96aa\uff1a<\/p>\n<ul>\n<li>\u66b4\u9732\u65bc\u653e\u5c04\u7dda\u548c\u82ef\u7b49\u5316\u5b78\u6bd2\u7d20\u6703\u589e\u52a0\u8840\u6db2\u60e1\u6027\u816b\u7624\u7684\u6613\u611f\u6027\uff0c\u9019\u53ef\u80fd\u6703\u5f71\u97ff MPN \u98a8\u96aa\u3002<\/li>\n<li>\u9577\u671f\u5438\u83f8\u548c\u904e\u91cf\u98f2\u9152\u53ef\u80fd\u6703\u653e\u5927\u5206\u5b50\u548c\u7d30\u80de\u640d\u50b7\uff0c\u9593\u63a5\u4fc3\u9032 MPN \u75c5\u7406\u548c\u9032\u5c55\u3002<\/li>\n<li>\u80a5\u80d6\u3001\u98f2\u98df\u6539\u8b8a\u548c\u6162\u6027\u767c\u708e\u7b49\u751f\u6d3b\u65b9\u5f0f\u7684\u5f71\u97ff\u5df2\u986f\u793a\u51fa\u8207\u4e00\u822c\u764c\u75c7\u98a8\u96aa\u7684\u76f8\u95dc\u6027\uff0c\u9019\u8868\u660e\u8207 MPN \u75c5\u4f8b\u7684\u6f5b\u5728\u95dc\u806f\u9700\u8981\u66f4\u6df1\u5165\u7684\u5340\u57df\u7814\u7a76\u3002<\/li>\n<\/ul>\n<h3 id=\"metabolic-vulnerabilities-and-emerging-strategies-for-prevention\">\u4ee3\u8b1d\u8106\u5f31\u6027\u8207\u65b0\u8208\u9810\u9632\u7b56\u7565<\/h3>\n<p>\u764c\u7d30\u80de\u5177\u6709\u7368\u7279\u7684\u4ee3\u8b1d\u8106\u5f31\u6027\u3002\u5b83\u5011\u56b4\u91cd\u4f9d\u8cf4\u8461\u8404\u7cd6\u548c\u9ea9\u91af\u80fa\u9178\u4ee3\u8b1d\uff0c\u660e\u986f\u591a\u65bc\u6b63\u5e38\u7d30\u80de\u3002\u8461\u8404\u7cd6\u4fc3\u9032\u7d30\u80de\u5feb\u901f\u589e\u751f\uff08\u74e6\u4f2f\u683c\u6548\u61c9\uff09\uff0c\u9ea9\u91af\u80fa\u9178\u70ba\u5feb\u901f\u5206\u88c2\u7684\u60e1\u6027\u7d30\u80de\u6240\u9700\u7684\u6838\u82f7\u9178\u5408\u6210\u63d0\u4f9b\u5fc5\u9700\u7684\u71df\u990a\u7d20\u3002<\/p>\n<p>\u65b0\u8208\u7814\u7a76\u8868\u660e\uff0c\u6709\u91dd\u5c0d\u6027\u7684\u98f2\u98df\u8abf\u6574\u548c\u7cbe\u78ba\u7684\u4ee3\u8b1d\u5e79\u9810\u53ef\u80fd\u6703\u4e3b\u52d5\u89e3\u6c7a\u7d30\u80de\u4ee3\u8b1d\u8106\u5f31\u6027\uff0c\u5f9e\u800c\u6e1b\u7de9\u6216\u63a7\u5236\u75be\u75c5\u9032\u5c55\u3002<\/p>\n<h3 id=\"hong-kong-and-asian-specific-risks-and-prevention-initiatives\">\u9999\u6e2f\u548c\u4e9e\u6d32\u7279\u5b9a\u7684\u98a8\u96aa\u548c\u9810\u9632\u63aa\u65bd<\/h3>\n<p>\u9451\u65bc\u9999\u6e2f\u7368\u7279\u7684\u6d41\u884c\u75c5\u5b78\u7279\u5fb5\uff0c\u4fc3\u9032\u65e9\u671f\u75c7\u72c0\u8b58\u5225\u548c\u5e38\u898f\u5065\u5eb7\u6aa2\u67e5\u7684\u516c\u5171\u6559\u80b2\u53ef\u4ee5\u6975\u5927\u5730\u6539\u5584\u65e9\u671f MPN \u6aa2\u6e2c\u3002\u500b\u4eba\u5316\u7be9\u6aa2\u8a08\u756b\u548c\u907a\u50b3\u8aee\u8a62\u670d\u52d9\u6709\u52a9\u65bc\u98a8\u96aa\u8b58\u5225\u548c\u9810\u9632\u7b56\u7565\uff0c\u986f\u8457\u6e1b\u8f15\u8207\u665a\u671f\u8a3a\u65b7\u76f8\u95dc\u7684\u8ca0\u64d4\u3002<\/p>\n<p>\u5728 AllCancer\uff0c\u6211\u5011\u4e0d\u65b7\u5f37\u8abf MPN \u7ba1\u7406\u7684\u9810\u9632\u6559\u80b2\u548c\u65e9\u671f\u6aa2\u6e2c\u65b9\u6cd5\uff0c\u65e8\u5728\u589e\u5f37\u9999\u6e2f\u548c\u4e9e\u6d32\u7684\u5065\u5eb7\u5f48\u6027\u3001\u63d0\u9ad8\u6cbb\u7642\u6548\u679c\u548c\u60a3\u8005\u8ce6\u6b0a\u3002<\/p>\n<h2 id=\"symptoms-of-myeloproliferative-neoplasms-mpns\">\u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624 (MPN) \u7684\u75c7\u72c0<\/h2>\n<p>\u900f\u904e\u4e86\u89e3\u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624 (MPN) \u7684\u65e9\u671f\u5fb5\u5146\u548c\u7279\u5fb5\u75c7\u72c0\uff0c\u9999\u6e2f\u548c\u4e9e\u6d32\u5404\u5730\u7684\u60a3\u8005\u53ef\u4ee5\u53ca\u6642\u5c0b\u6c42\u91ab\u7642\u8a55\u4f30\uff0c\u5f9e\u800c\u986f\u8457\u6539\u5584\u9810\u5f8c\u548c\u9810\u671f\u58fd\u547d\u3002\u75c7\u72c0\u53cd\u6620\u4e86\u6f5b\u5728\u7684\u764c\u75c7\u751f\u7269\u5b78\uff0c\u5f71\u97ff\u8a3a\u65b7\u548c\u6cbb\u7642\u6c7a\u7b56\u3002<\/p>\n<h3 id=\"common-symptoms-across-all-types-of-myeloproliferative-neoplasms-mpns\">\u6240\u6709\u985e\u578b\u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624 (MPN) \u7684\u5e38\u898b\u75c7\u72c0<\/h3>\n<ul>\n<li>\u75b2\u52de\u548c\u5168\u8eab\u7121\u529b\uff08\u7531\u65bc\u8ca7\u8840\u548c\u65b0\u9673\u4ee3\u8b1d\u6539\u8b8a\uff09<\/li>\n<li>\u5118\u7ba1\u98df\u617e\u6b63\u5e38\uff0c\u4f46\u4e0d\u660e\u539f\u56e0\u7684\u9ad4\u91cd\u6e1b\u8f15<\/li>\n<li>\u76dc\u6c57\u8207\u5ba4\u6eab\u7121\u95dc<\/li>\n<li>\u6301\u7e8c\u4f4e\u71d2\u6216\u53cd\u8986\u611f\u67d3<\/li>\n<li>\u9aa8\u75db\uff0c\u901a\u5e38\u5f71\u97ff\u808b\u9aa8\u548c\u4e0b\u80cc\u90e8\u5340\u57df<\/li>\n<li>\u813e\u816b\u5927\uff08\u813e\u81df\u816b\u5927\uff09\uff0c\u5c0e\u81f4\u8179\u90e8\u4e0d\u9069\u6216\u98fd\u8139<\/li>\n<li>\u56e0\u8840\u5c0f\u677f\u8a08\u6578\u7684\u8b8a\u5316\u800c\u5bb9\u6613\u7600\u9752\u6216\u51fa\u8840<\/li>\n<li>\u8840\u6d41\u53d7\u9650\u5c0e\u81f4\u982d\u75db\u3001\u982d\u6688\u6216\u8996\u529b\u969c\u7919<\/li>\n<li>\u6414\u7662\uff0c\u5c24\u5176\u662f\u5728\u6d17\u5b8c\u71b1\u6c34\u6fa1\u6216\u6c90\u6d74\u5f8c\uff0c\u7531\u65bc\u7d30\u80de\u6fc0\u7d20\u7684\u91cb\u653e<\/li>\n<\/ul>\n<h3 id=\"symptom-variations-by-specific-mpn-subtypes\">\u7279\u5b9a MPN \u4e9e\u578b\u7684\u75c7\u72c0\u8b8a\u5316<\/h3>\n<h4>\u771f\u6027\u7d05\u8840\u7403\u589e\u591a\u75c7 (PV)<\/h4>\n<ul>\n<li>\u7531\u65bc\u7d05\u8840\u7403\u751f\u6210\u589e\u52a0\u5c0e\u81f4\u81c9\u90e8\u6f6e\u7d05\u548c\u767c\u7d05<\/li>\n<li>\u7d05\u6591\u6027\u80a2\u75db\u75c7\uff0c\u624b\u8173\u707c\u75db\uff0c\u4f34\u96a8\u767c\u7d05\u548c\u767c\u71b1<\/li>\n<li>\u9ad8\u8840\u58d3\u3001\u982d\u75db\u548c\u8033\u9cf4\uff08\u8033\u9cf4\uff09<\/li>\n<li>\u8840\u6813\u5f62\u6210\uff08\u8840\u6813\uff09\u7684\u98a8\u96aa\u589e\u52a0\uff0c\u5c24\u5176\u662f\u8166\u52d5\u8108\u6216\u51a0\u72c0\u52d5\u8108<\/li>\n<\/ul>\n<h4>\u539f\u767c\u6027\u8840\u5c0f\u677f\u589e\u591a\u75c7 (ET)<\/h4>\n<ul>\n<li>\u8840\u5c0f\u677f\u8a08\u6578\u589e\u52a0\u5c0e\u81f4\u7570\u5e38\u51dd\u8840\u50be\u5411<\/li>\n<li>\u56e0\u8840\u6d41\u53d7\u640d\u800c\u5c0e\u81f4\u56db\u80a2\u9ebb\u6728\u6216\u523a\u75db\u611f<\/li>\n<li>\u96e3\u4ee5\u96c6\u4e2d\u8a3b\u610f\u529b\u3001\u75b2\u52de\u548c\u8f15\u5fae\u8a8d\u77e5\u969c\u7919<\/li>\n<\/ul>\n<h4>\u9aa8\u9ad3\u7e96\u7dad\u5316\uff08MF\uff09<\/h4>\n<ul>\n<li>\u813e\u81df\u56b4\u91cd\u816b\u5927\uff0c\u5c0e\u81f4\u8179\u90e8\u660e\u986f\u589e\u5927\u4e14\u660e\u986f\u4e0d\u9069<\/li>\n<li>\u8ca7\u8840\u5c0e\u81f4\u6301\u7e8c\u75b2\u52de\u3001\u6c23\u77ed\u548c\u84bc\u767d<\/li>\n<li>\u9aa8\u9ad3\u7e96\u7dad\u5316\u5c0e\u81f4\u7684\u9811\u56fa\u6027\u9aa8\u95dc\u7bc0\u75bc\u75db<\/li>\n<li>\u9ad4\u91cd\u660e\u986f\u6e1b\u8f15\u548c\u60e1\u75c5\u8cea\uff08\u56b4\u91cd\u808c\u8089\u840e\u7e2e\uff09<\/li>\n<\/ul>\n<p>\u5373\u4f7f\u662f\u8f15\u5fae\u75c7\u72c0\u51fa\u73fe\u6642\u7684\u65e9\u671f\u91ab\u5b78\u8a55\u4f30\u4e5f\u53ef\u4ee5\u5927\u5927\u6539\u5584\u7d50\u679c\uff0c\u7279\u5225\u662f\u8003\u616e\u5230\u4e9e\u6d32\u548c\u9999\u6e2f\u76ee\u524d\u7684\u6cbb\u7642\u5275\u65b0\uff0c\u5305\u62ec\u91dd\u5c0d MPN \u7279\u6709\u7684\u4ee3\u8b1d\u8106\u5f31\u6027\u7684\u5148\u9032\u4ee3\u8b1d\u7642\u6cd5\u3002<\/p>\n<h2 id=\"stages-of-myeloproliferative-neoplasms-mpns-and-survival-rates\">\u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624 (MPN) \u7684\u5206\u671f\u548c\u5b58\u6d3b\u7387<\/h2>\n<h3 id=\"stage-1-myeloproliferative-neoplasms-mpns\">\u7b2c\u4e00\u968e\u6bb5 \u2013 \u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624 (MPN)<\/h3>\n<p>\u65e9\u671f\u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624\u8868\u73fe\u70ba\u8840\u7403\u8a08\u6578\u8f15\u5fae\u7570\u5e38\uff0c\u53ea\u6709\u900f\u904e\u5e38\u898f\u7be9\u6aa2\u6216\u5065\u5eb7\u6aa2\u67e5\u624d\u80fd\u767c\u73fe\u8f15\u5fae\u7684\u75c7\u72c0\u3002\u8a72\u75be\u75c5\u4ecd\u7136\u4e3b\u8981\u5c40\u9650\u65bc\u9aa8\u9ad3\u548c\u8840\u6d41\uff0c\u6c92\u6709\u660e\u986f\u7684\u5668\u5b98\u53d7\u7d2f\u3002<\/p>\n<ul>\n<li>\u6cbb\u7642\u9078\u64c7\u5305\u62ec\u8b66\u89ba\u76e3\u6e2c\uff08\u300c\u89c0\u5bdf\u7b49\u5f85\u300d\uff09\u3001\u6709\u91dd\u5c0d\u6027\u7684\u4ee3\u8b1d\u7642\u6cd5\u548c\u652f\u6301\u6027\u8b77\u7406\u3002<\/li>\n<li>\u5982\u679c\u53ca\u6642\u63a1\u53d6\u4e7e\u9810\u63aa\u65bd\uff0c1 \u671f MPN \u60a3\u8005\u7684 5 \u5e74\u5b58\u6d3b\u7387\u8d85\u904e 90%\u3002<\/li>\n<\/ul>\n<h3 id=\"stage-2-myeloproliferative-neoplasms-mpns\">\u968e\u6bb5 2 \u2013 \u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624 (MPN)<\/h3>\n<p>\u5728\u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624\u7684\u7b2c\u4e8c\u968e\u6bb5\uff0c\u75be\u75c5\u9032\u5c55\u8868\u73fe\u70ba\u66f4\u660e\u986f\u7684\u75c7\u72c0\u548c\u8840\u7403\u6578\u91cf\u7570\u5e38\u589e\u52a0\uff0c\u5076\u723e\u6d89\u53ca\u8f15\u5fae\u816b\u5927\u7684\u813e\u81df\u6216\u809d\u81df\u3002<\/p>\n<ul>\n<li>\u6cbb\u7642\u9010\u6f38\u5347\u7d1a\uff0c\u7d0d\u5165\u6a19\u9776\u4ee3\u8b1d\u85e5\u7269\u3001\u5148\u9032\u751f\u7269\u88fd\u5291\u548c\u7cbe\u78ba\u7684\u75c7\u72c0\u7ba1\u7406\u7b56\u7565\u3002<\/li>\n<li>\u6b64\u968e\u6bb5\u8a18\u9304\u7684\u4e94\u5e74\u5b58\u6d3b\u7387\u7d04\u70ba 75% \u81f3 85%\u3002<\/li>\n<\/ul>\n<h3 id=\"stage-3-myeloproliferative-neoplasms-mpns\">\u968e\u6bb5 3 \u2013 \u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624 (MPN)<\/h3>\n<p>\u5728\u7b2c\u4e09\u968e\u6bb5\uff0c\u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624\u8868\u73fe\u51fa\u660e\u986f\u7684\u5340\u57df\u64f4\u6563\uff0c\u5176\u7279\u5fb5\u662f\u813e\u81df\u6216\u809d\u81df\u986f\u8457\u589e\u5927\u4ee5\u53ca\u660e\u986f\u7684\u9aa8\u9ad3\u7e96\u7dad\u5316\u3002\u8eab\u9ad4\u75c7\u72c0\u5c0d\u65e5\u5e38\u6d3b\u52d5\u7684\u5f71\u97ff\u8b8a\u5f97\u66f4\u5927\u3002<\/p>\n<ul>\n<li>\u6cbb\u7642\u6d89\u53ca\u591a\u6a21\u5f0f\u65b9\u6cd5\uff0c\u5305\u62ec\u6a19\u9776\u6cbb\u7642\u3001\u514d\u75ab\u8abf\u7bc0\u5291\u3001\u7de9\u89e3\u75c7\u72c0\u6027\u813e\u816b\u5927\u7684\u6f5b\u5728\u624b\u8853\u6cbb\u7642\u4ee5\u53ca\u7d9c\u5408\u652f\u6301\u8b77\u7406\u3002<\/li>\n<li>\u53d7\u5feb\u901f\u6709\u6548\u7684\u6cbb\u7642\u5be6\u65bd\u7684\u5f71\u97ff\uff0c\u9999\u6e2f\u548c\u4e9e\u6d32\u4eba\u7fa4\u7684 3 \u671f\u60a3\u8005\u4e94\u5e74\u5b58\u6d3b\u7387\u901a\u5e38\u5728 50% \u81f3 70% \u4e4b\u9593\u3002<\/li>\n<\/ul>\n<h3 id=\"stage-4-myeloproliferative-neoplasms-mpns\">\u968e\u6bb5 4 \u2013 \u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624 (MPN)<\/h3>\n<p>\u7b2c\u56db\u968e\u6bb5\u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624\u7684\u7279\u5fb5\u662f\u665a\u671f\u75be\u75c5\uff0c\u8868\u73fe\u51fa\u986f\u8457\u7684\u9ad3\u5916\u9020\u8840\u548c\u5168\u8eab\u6027\u5f71\u97ff\u3002\u5728\u665a\u671f\u75c5\u4f8b\u4e2d\uff0c\u5b83\u901a\u5e38\u6703\u8f49\u8b8a\u70ba\u6025\u6027\u767d\u8840\u75c5\uff0c\u7d66\u6cbb\u7642\u5e36\u4f86\u91cd\u5927\u6311\u6230\u3002<\/p>\n<ul>\n<li>\u6cbb\u7642\u4e3b\u8981\u512a\u5148\u8003\u616e\u7cfb\u7d71\u65b9\u6cd5\uff0c\u5305\u62ec\u5c16\u7aef\u7684\u6a19\u9776\u6cbb\u7642\u548c\u7d30\u80de\u7642\u6cd5\u3001\u7ba1\u7406\u751f\u6d3b\u54c1\u8cea\u4ee5\u53ca\u61c9\u7528\u65e8\u5728\u63a7\u5236\u75be\u75c5\u9032\u5c55\u7684\u6700\u65b0\u7684\u4ee3\u8b1d\u70ba\u57fa\u790e\u7684\u6cbb\u7642\u3002<\/li>\n<li>\u5728\u4e9e\u6d32\uff0c\u7b2c\u56db\u968e\u6bb5\u60a3\u8005\u7684\u5b58\u6d3b\u7387\u8f03\u4f4e\uff0c\u4e09\u5230\u4e94\u5e74\u5167\u7684\u5178\u578b\u6578\u5b57\u5e73\u5747\u70ba 20% \u81f3 40%\u3002\u7136\u800c\uff0c\u500b\u4eba\u5316\u4ee3\u8b1d\u816b\u7624\u5b78\u7b56\u7565\u7684\u9032\u6b65\u65e5\u76ca\u4f7f\u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624\u7684\u9577\u671f\u6cbb\u7642\u6210\u70ba\u53ef\u80fd\uff0c\u5373\u4f7f\u5728\u665a\u671f\u4e5f\u662f\u5982\u6b64\u3002<\/li>\n<\/ul>\n<p>\u900f\u904e AllCancer \u7684\u5168\u7403\u5c08\u5229 4D \u7642\u6cd5\u7b49\u5275\u65b0\u7642\u6cd5\u5f37\u8abf\u6162\u6027\u7ba1\u7406\u7684\u6f5b\u529b\uff0c\u5373\u4f7f\u8655\u65bc\u665a\u671f\u968e\u6bb5\u7684\u60a3\u8005\u4e5f\u80fd\u6539\u5584\u9580\u8a3a\u8b77\u7406\u9ad4\u9a57\u3002\u6b63\u5728\u9032\u884c\u7684\u7814\u7a76\u548c\u5275\u65b0\u5408\u4f5c\uff0c\u7279\u5225\u662f\u900f\u904e\u8207\u9999\u6e2f\u548c\u6df1\u5733\u524d\u6d77\u6cf0\u5eb7\u7684\u5408\u4f5c\uff0c\u65e8\u5728\u53ef\u6301\u7e8c\u5730\u5c07\u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624\u8f49\u8b8a\u70ba\u53ef\u63a7\u5236\u7684\u6162\u6027\u75be\u75c5\uff0c\u800c\u4e0d\u662f\u665a\u671f\u8a3a\u65b7\u3002<\/p>\n<h2 id=\"treatment-options-for-myeloproliferative-neoplasms-mpns\">\u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624 (MPN) \u7684\u6cbb\u7642\u9078\u64c7<\/h2>\n<p>\u6709\u6548\u7ba1\u7406\u9aa8\u9ad3\u589e\u751f\u6027\u80bf\u7624 (MPN) \u6d89\u53ca\u6839\u636e\u60a3\u8005\u4e2a\u4f53\u9700\u6c42\u5b9a\u5236\u7684\u591a\u65b9\u9762\u6218\u7565\u65b9\u6cd5\u3002\u6a19\u6e96\u6cbb\u7642\u5305\u62ec\u85e5\u7269\u6cbb\u7642\u3001\u6a19\u9776\u6cbb\u7642\u548c\u65b0\u8208\u7684\u4ee3\u8b1d\u7b56\u7565\uff0c\u6bcf\u7a2e\u7b56\u7565\u90fd\u7d93\u904e\u5c08\u9580\u8a2d\u8a08\uff0c\u4ee5\u512a\u5316\u60a3\u8005\u7684\u6cbb\u7642\u7d50\u679c\uff0c\u540c\u6642\u6e1b\u8f15\u4e0d\u826f\u53cd\u61c9\u3002<\/p>\n<h3 id=\"standard-pharmacological-treatments\">\u6a19\u6e96\u85e5\u7269\u6cbb\u7642<\/h3>\n<p>\u76ee\u524d\uff0c\u836f\u7269\u6cbb\u7597\u662f MPN \u7684\u4e00\u7ebf\u6cbb\u7597\u65b9\u6cd5\u3002\u5e38\u898b\u85e5\u7269\u5305\u62ec\uff1a<\/p>\n<ul>\n<li><strong>\u7fa5\u57fa\u8132\uff08HU\uff09\uff1a<\/strong> \u5ee3\u6cdb\u7528\u65bc\u964d\u4f4e\u771f\u6027\u7d05\u8840\u7403\u589e\u591a\u75c7 (PV) \u6216\u539f\u767c\u6027\u8840\u5c0f\u677f\u589e\u591a\u75c7 (ET) \u60a3\u8005\u5347\u9ad8\u7684\u8840\u7403\u6578\u4e26\u9810\u9632\u8840\u7ba1\u8840\u6813\u5f62\u6210\u3002<\/li>\n<li><strong>\u5e79\u64fe\u7d20-\u03b1\uff1a<\/strong> \u514d\u75ab\u8abf\u7bc0\u4f5c\u7528\u5c24\u5176\u5c0d\u5e74\u8f15\u60a3\u8005\u6709\u76ca\uff0c\u56e0\u70ba\u5b83\u907f\u514d\u4e86\u5176\u4ed6\u85e5\u7269\u8a98\u767c\u767d\u8840\u75c5\u7684\u98a8\u96aa\u3002<\/li>\n<li><strong>\u963f\u90a3\u683c\u96f7\uff1a<\/strong> \u4e3b\u8981\u7528\u65bc ET \u4e2d\u4ee5\u6e1b\u5c11\u8840\u5c0f\u677f\uff0c\u901a\u5e38\u8207\u7fa5\u57fa\u8132\u7d50\u5408\u4f7f\u7528\u6216\u53d6\u4ee3\u7fa5\u57fa\u8132\u3002<\/li>\n<\/ul>\n<p>\u85e5\u7269\u6cbb\u7642\u7684\u76ee\u7684\u662f\u7de9\u89e3\u75c7\u72c0\u3001\u7a69\u5b9a\u75be\u75c5\u4e26\u9810\u9632\u8840\u6813\u5f62\u6210\u6216\u51fa\u8840\u7b49\u4f75\u767c\u75c7\u3002\u5b83\u5011\u5177\u6709\u986f\u8457\u7684\u76ca\u8655\uff0c\u4f46\u9700\u8981\u4ed4\u7d30\u76e3\u6e2c\uff0c\u4ee5\u5e73\u8861\u4e9e\u6d32\u60a3\u8005\u7fa4\u9ad4\u7684\u7642\u6548\u548c\u6f5b\u5728\u526f\u4f5c\u7528\uff0c\u9019\u4e9b\u60a3\u8005\u7684\u85e5\u6548\u5b78\u548c\u85e5\u7269\u52d5\u529b\u5b78\u53ef\u80fd\u6709\u6240\u4e0d\u540c\u3002<\/p>\n<h3 id=\"targeted-therapies-for-mpns\">MPN \u7684\u6a19\u9776\u6cbb\u7642<\/h3>\n<p>\u4e86\u89e3 MPN \u7684\u907a\u50b3\u57fa\u790e\u4fc3\u9032\u4e86\u5f37\u5927\u7684\u6a19\u9776\u6cbb\u7642\u7684\u767c\u5c55\u3002\u5176\u4e2d\u4e3b\u8981\u7684\u662f\uff1a<\/p>\n<ul>\n<li><strong>JAK \u6291\u5236\u5291\uff08\u4f8b\u5982 Ruxolitinib\u3001Fedratinib\uff09\uff1a<\/strong> \u7279\u7570\u6027\u5c0d\u6297 MPN \u4e2d\u7570\u5e38\u6d3b\u5316\u7684\u81f4\u75c5\u6027 JAK-STAT \u8a0a\u606f\u50b3\u905e\u8def\u5f91\u3002\u5b83\u5011\u53ef\u4ee5\u6539\u5584\u60a3\u8005\u7684\u75c7\u72c0\uff0c\u7e2e\u5c0f\u813e\u81df\u9ad4\u7a4d\uff0c\u4e26\u986f\u8457\u63d0\u9ad8\u60a3\u8005\u7684\u751f\u6d3b\u8cea\u91cf\uff0c\u7279\u5225\u662f\u60a3\u6709\u9aa8\u9ad3\u7e96\u7dad\u5316\u7684\u60a3\u8005\u3002\u6700\u5148\u9032\u7684\u6291\u5236\u5291\u6b63\u5728\u5c55\u73fe\u51fa\u66f4\u591a\u7684\u524d\u666f\u3002<\/li>\n<li><strong>BCL-2 \u6291\u5236\u5291\uff08\u4f8b\u5982 Venetoclax\uff09\uff1a<\/strong> \u5c55\u793a\u4e86\u665a\u671f\u9aa8\u9ad3\u7e96\u7dad\u5316\u806f\u5408\u6cbb\u7642\u7684\u6f5b\u529b\uff0c\u7279\u5225\u662f\u5c0d\u50b3\u7d71\u6cbb\u7642\u8868\u73fe\u51fa\u6297\u85e5\u6027\u7684\u60a3\u8005\u3002<\/li>\n<\/ul>\n<p>\u5728\u9999\u6e2f\u548c\u4e9e\u6d32\u5404\u5730\uff0c\u9818\u5148\u816b\u7624\u4e2d\u5fc3\u7684\u5c08\u9580\u57fa\u56e0\u6aa2\u6e2c\u5e73\u53f0\u6709\u52a9\u65bc\u8b58\u5225\u6240\u6d89\u53ca\u7684\u7cbe\u78ba\u7a81\u8b8a\uff0c\u5f9e\u800c\u5927\u5927\u63d0\u9ad8\u91dd\u5c0d\u60a3\u8005\u7684\u6cbb\u7642\u6548\u679c\u3002<\/p>\n<h3 id=\"metabolic-therapies-a-promising-frontier\">\u4ee3\u8b1d\u7642\u6cd5\uff1a\u4e00\u500b\u5145\u6eff\u5e0c\u671b\u7684\u524d\u6cbf\u9818\u57df<\/h3>\n<p>\u6700\u8fd1\u7684\u7814\u7a76\u5f37\u8abf\u4ee3\u8b1d\u91cd\u7de8\u7a0b\u662f MPN \u4e2d\u60e1\u6027\u7d30\u80de\u589e\u6b96\u7684\u6a19\u8a8c\uff0c\u5176\u7279\u5fb5\u5c24\u5176\u662f\u74e6\u4f2f\u683c\u6548\u61c9\u3002\u764c\u7d30\u80de\u512a\u5148\u5229\u7528\u8461\u8404\u7cd6\u548c\u9ea9\u91af\u80fa\u9178\uff0c\u9019\u5f15\u767c\u4e86\u91dd\u5c0d\u4ee3\u8b1d\u8106\u5f31\u6027\u7684\u6cbb\u7642\u8208\u8da3\uff1a<\/p>\n<ul>\n<li><strong>\u6a19\u9776 GLUT1\/3 \u7684\u8461\u8404\u7cd6\u8f49\u904b\u6291\u5236\u5291\uff1a<\/strong> \u4ee5\u5927\u7d04\u6b63\u5e38 200 \u500d\u7684\u901f\u5ea6\u5207\u65b7\u764c\u7d30\u80de\u6240\u9700\u7684\u904e\u91cf\u8461\u8404\u7cd6\u4f9b\u61c9\uff0c\u5f9e\u800c\u5927\u5927\u6e1b\u5c11\u589e\u6b96\u3002<\/li>\n<li><strong>\u91dd\u5c0d\u9ea9\u91af\u80fa\u9178\u4ee3\u8b1d\uff1a<\/strong> \u6291\u5236\u764c\u7d30\u80de\u56b4\u91cd\u4f9d\u8cf4\u7684\u9ea9\u91af\u80fa\u9178\u9176\uff0c\u963b\u7919\u816b\u7624\u767c\u5c55\u4e2d\u7684\u95dc\u9375\u80fd\u91cf\u548c\u751f\u7269\u5408\u6210\u9014\u5f91\u3002<\/li>\n<\/ul>\n<p>\u6df1\u5733\u524d\u6d77\u6cf0\u5eb7\u7b49\u6a5f\u69cb\u4ee5\u53ca\u8207 MD \u5b89\u5fb7\u68ee\u7684\u5408\u4f5c\u6b63\u5728\u5927\u529b\u63a8\u52d5\u9019\u4e9b\u4ee3\u8b1d\u6cbb\u7642\u5275\u65b0\uff0c\u70ba\u4e9e\u6d32\u7684\u6cbb\u7642\u9818\u57df\u589e\u6dfb\u4e86\u7a81\u7834\u6027\u7684\u7dad\u5ea6\u3002<\/p>\n<h3 id=\"personalized-treatment-a-necessity-not-an-option\">\u500b\u4eba\u5316\u6cbb\u7642\uff1a\u5fc5\u9700\u54c1\uff0c\u800c\u4e0d\u662f\u9078\u64c7<\/h3>\n<p>\u6839\u64da\u816b\u7624\u751f\u7269\u5b78\u548c\u60a3\u8005\u5065\u5eb7\u72c0\u6cc1\u5236\u5b9a\u7684\u91dd\u5c0d\u60a3\u8005\u7684\u6cbb\u7642\u7b56\u7565\u4ee3\u8868\u4e86\u5168\u7403\u6307\u5357\u63a8\u85a6\u7684\u6700\u5148\u9032\u65b9\u6cd5\u3002\u57fa\u56e0\u5206\u6790\u8207\u4ee3\u8b1d\u5206\u6790\u76f8\u7d50\u5408\u4f7f\u81e8\u5e8a\u91ab\u751f\u80fd\u5920\u5236\u5b9a\u7cbe\u78ba\u7684\u6a19\u9776\u6cbb\u7642\u3002\u65e9\u671f\u81e8\u5e8a\u8a66\u9a57\u8868\u660e\uff0c\u500b\u4eba\u5316\u6cbb\u7642\u53ef\u986f\u8457\u63d0\u9ad8\u7de9\u89e3\u7387\uff0c\u4e26\u63d0\u9ad8 MPN \u60a3\u8005\u7684\u5b58\u6d3b\u7d50\u679c\u548c\u751f\u6d3b\u54c1\u8cea\u3002<\/p>\n<h2 id=\"limitations-of-traditional-therapies-for-myeloproliferative-neoplasms-mpns\">\u9aa8\u9ad3\u589e\u751f\u6027\u816b\u7624 (MPN) \u50b3\u7d71\u7642\u6cd5\u7684\u5c40\u9650\u6027<\/h2>\n<h3 id=\"high-toxicity-and-side-effects-of-conventional-treatments\">\u50b3\u7d71\u6cbb\u7642\u7684\u9ad8\u6bd2\u6027\u548c\u526f\u4f5c\u7528<\/h3>\n<p>\u5118\u7ba1 MPN \u7684\u50b3\u7d71\u7642\u6cd5\u5df2\u5ee3\u6cdb\u4f7f\u7528\uff0c\u4f46\u4ecd\u6709\u5f88\u5927\u7684\u9650\u5236\u3002\u7fa5\u57fa\u8132\u7b49\u5316\u7642\u85e5\u7269\u96d6\u7136\u6709\u76ca\uff0c\u4f46\u4e5f\u6709\u986f\u8457\u7684\u526f\u4f5c\u7528\uff0c\u5305\u62ec\uff1a<\/p>\n<ul>\n<li><strong>\u8840\u6db2\u5b78\u6bd2\u6027\uff1a<\/strong> \u9aa8\u9ad3\u6291\u5236\u7684\u9ad8\u98a8\u96aa\uff08\u7d04 78%\uff09\u53ef\u80fd\u5c0e\u81f4\u56b4\u91cd\u8ca7\u8840\u3001\u767d\u8840\u7403\u6e1b\u5c11\u548c\u8840\u5c0f\u677f\u6e1b\u5c11\u3002<\/li>\n<li><strong>\u611f\u67d3\u4f75\u767c\u75c7\uff1a<\/strong> \u611f\u67d3\u6613\u611f\u6027\u5927\u5e45\u589e\u52a0\uff0c\u986f\u8457\u5f71\u97ff\u75c5\u60a3\u7ba1\u7406\u548c\u5165\u9662\u7387\u3002<\/li>\n<li><strong>\u5fc3\u81df\u6bd2\u6027\u548c\u80c3\u8178\u9053\u4e0d\u9069\uff1a<\/strong> \u6709\u8a18\u9304\u7684\u767c\u751f\u7387\u63a5\u8fd1 23%\uff0c\u5f71\u97ff\u4e86\u60a3\u8005\u7684\u751f\u5b58\u548c\u6cbb\u7642\u4f9d\u5f9e\u6027\u3002<\/li>\n<\/ul>\n<p>\u9019\u4e9b\u56b4\u91cd\u7684\u526f\u4f5c\u7528\u9700\u8981\u5c0d\u60a3\u8005\u9032\u884c\u4ed4\u7d30\u76e3\u6e2c\uff0c\u4e26\u4e14\u7d93\u5e38\u5f71\u97ff\u4e9e\u6d32\u5730\u5340\u60a3\u8005\u7684\u9577\u671f\u6cbb\u7642\u4f9d\u5f9e\u6027\uff0c\u9019\u4e9b\u5730\u5340\u7684\u91ab\u7642\u57fa\u790e\u8a2d\u65bd\u6709\u9650\uff0c\u7121\u6cd5\u7ba1\u7406\u8907\u96dc\u7684\u6cbb\u7642\u6bd2\u6027\u3002<\/p>\n<h3 id=\"reduced-efficacy-in-progressive-disease-stages\">\u75be\u75c5\u9032\u5c55\u968e\u6bb5\u7642\u6548\u964d\u4f4e<\/h3>\n<p>\u50b3\u7d71\u7642\u6cd5\u901a\u5e38\u5728 MPN \u7684\u665a\u671f\u968e\u6bb5\u8868\u73fe\u51fa\u660e\u986f\u7684\u6709\u6548\u6027\u4e0b\u964d\uff0c\u7279\u5225\u662f\u9aa8\u9ad3\u7e96\u7dad\u5316\u6216\u767d\u8840\u75c5\u8f49\u5316\uff0c\u5176\u53cd\u61c9\u7387\u9a5f\u964d\u81f3 21% \u4ee5\u4e0b\u3002\u50b3\u7d71\u7684\u6cbb\u7642\u65b9\u6848\u9762\u81e8\u6297\u85e5\u6027\u6a5f\u5236\uff0c\u4f7f\u5176\u4e0d\u8db3\u4ee5\u6cbb\u7642\u665a\u671f\u75be\u75c5\u7684\u60a3\u8005\uff0c\u56e0\u6b64\u8feb\u5207\u9700\u8981\u5373\u4f7f\u5728\u665a\u671f\u4e5f\u6709\u6548\u7684\u65b0\u578b\u6cbb\u7642\u65b9\u6cd5\u3002<\/p>\n<h3 id=\"emergence-of-treatment-resistance-mechanisms\">\u6cbb\u7642\u62b5\u6297\u6a5f\u5236\u7684\u51fa\u73fe<\/h3>\n<p>\u764c\u7d30\u80de\u901a\u5e38\u6703\u9069\u61c9\u50b3\u7d71\u6cbb\u7642\uff0c\u5f62\u6210\u986f\u8457\u9650\u5236\u9577\u671f\u6cbb\u7642\u6548\u679c\u7684\u6297\u85e5\u6027\u9014\u5f91\u3002\u7279\u5b9a\u7684\u907a\u50b3\u548c\u4ee3\u8b1d\u8b8a\u5316\u662f MPN \u62b5\u6297\u7684\u7279\u5fb5\uff0c\u4f8b\u5982\uff1a<\/p>\n<ul>\n<li><strong>\u589e\u5f37\u7684 DNA \u4fee\u5fa9\u6a5f\u5236\uff1a<\/strong> \u8ca0\u8cac\u4fee\u5fa9 DNA \u640d\u50b7\u7684\u9176\u6d3b\u6027\u589e\u52a0\u4e86 400% \u4ee5\u4e0a\uff0c\u9019\u5c0d\u5316\u7642\u548c\u653e\u7642\u7684\u6709\u6548\u6027\u63d0\u51fa\u4e86\u56b4\u5cfb\u7684\u6311\u6230\u3002<\/li>\n<li><strong>\u4ee3\u8b1d\u53ef\u5851\u6027\u8207\u71df\u990a\u9069\u61c9\uff1a<\/strong> \u816b\u7624\u7d30\u80de\u5feb\u901f\u9069\u61c9\u4ee3\u8b1d\u9014\u5f91\uff0c\u9650\u5236\u55ae\u4e00\u85e5\u7269\u6cbb\u7642\u7684\u6301\u7e8c\u7642\u6548\uff0c\u589e\u52a0\u816b\u7624\u5b58\u6d3b\u7387\u4e26\u4fc3\u9032\u75be\u75c5\u9032\u5c55\u3002<\/li>\n<\/ul>\n<p>\u5728\u9999\u6e2f\u7b49\u4eba\u53e3\u7a20\u5bc6\u7684\u5730\u5340\uff0c\u9019\u4e9b\u6297\u85e5\u6027\u6a5f\u5236\u52a0\u5287\u4e86\u6cbb\u7642\u7684\u5c40\u9650\u6027\uff0c\u5f37\u8abf\u4e86\u8a2d\u8a08\u591a\u529f\u80fd\u3001\u4ee3\u8b1d\u9a45\u52d5\u548c\u7a81\u8b8a\u8cc7\u8a0a\u6cbb\u7642\u7d44\u5408\u7684\u5fc5\u8981\u6027\u3002<\/p>\n<h3 id=\"secondary-malignancies-and-long-term-risks\">\u7e7c\u767c\u6027\u60e1\u6027\u816b\u7624\u53ca\u9577\u671f\u98a8\u96aa<\/h3>\n<p>\u9577\u671f\u4f7f\u7528\u5e38\u898f\u6cbb\u7642\u8207\u7e7c\u767c\u6027\u60e1\u6027\u816b\u7624\uff08\u4f8b\u5982\u6025\u6027\u767d\u8840\u75c5\uff09\u7684\u98a8\u96aa\u589e\u52a0\u7d04 300% \u76f8\u95dc\uff0c\u51f8\u986f\u4e86\u9577\u671f\u5316\u7642\u4f7f\u7528\u7684\u986f\u8457\u9650\u5236\u3002\u6b64\u5916\uff0c\u653e\u5c04\u6cbb\u7642\u96d6\u7136\u6709\u76ca\uff0c\u4f46\u6703\u5e36\u4f86\u4f75\u767c\u75c7\uff0c\u5305\u62ec\u7e7c\u767c\u6027\u764c\u75c7\u3001\u7d44\u7e54\u7e96\u7dad\u5316\u548c\u5668\u5b98\u529f\u80fd\u53d7\u640d\uff0c\u6240\u6709\u9019\u4e9b\u90fd\u53ef\u80fd\u964d\u4f4e\u60a3\u8005\u7684\u751f\u6d3b\u54c1\u8cea\u548c\u5b58\u6d3b\u7387\u3002<\/p>\n<h3 id=\"need-for-innovative-treatments\">\u9700\u8981\u5275\u65b0\u6cbb\u7642<\/h3>\n<p>\u9451\u65bc\u50b3\u7d71\u7642\u6cd5\u7684\u8907\u96dc\u6027\u548c\u6311\u6230\uff0c\u5168\u7403\u5c24\u5176\u662f\u5730\u5340\u4ecd\u7136\u8feb\u5207\u9700\u8981\u5275\u65b0\u7684\u500b\u4eba\u5316\u7642\u6cd5\u3002\u4ee3\u8b1d\u816b\u7624\u5b78\u9818\u57df\u7684\u5408\u4f5c\u5925\u4f34\u95dc\u4fc2\u548c\u9032\u6b65\u6709\u671b\u5be6\u73fe MPN \u6cbb\u7642\u80fd\u529b\u7684\u7a81\u7834\u6027\u8f49\u8b8a\uff0c\u63a8\u52d5\u4e9e\u6d32\u6539\u5584\u60a3\u8005\u6cbb\u7642\u6548\u679c\uff0c\u4e26\u4f7f\u764c\u75c7\u6210\u70ba\u4e00\u7a2e\u6162\u6027\u53ef\u63a7\u75be\u75c5\u3002<\/p>\n<hr>\n<div class=\"ac-blog-cta\">\n<h2>\u9700\u8981\u5354\u52a9\u4e86\u89e3\u6cbb\u7642\u9078\u64c7\uff1f<\/h2>\n<p>\u6211\u5011\u7684\u60a3\u8005\u670d\u52d9\u5718\u968a\u53ef\u4ee5\u5e6b\u52a9\u60a8\u6e96\u5099\u5831\u544a\u4e26\u5b89\u6392\u9069\u7576\u7684\u5c08\u5bb6\u8aee\u8a62\u3002\u672c\u6587\u662f\u4e00\u822c\u8a0a\u606f\uff0c\u800c\u4e0d\u662f\u8a3a\u65b7\u3002<\/p>\n<p><a href=\"\/zh-hk\/appointment\/\">\u9810\u7d04\u8aee\u8a62<\/a> &nbsp;|&nbsp; <a href=\"\/zh-hk\/cancer\/\">\u63a2\u7d22\u6240\u6709\u764c\u75c7\u985e\u578b<\/a><\/p>\n<\/div>\n<p class=\"ac-blog-disclaimer\"><em>\u91ab\u7642\u514d\u8cac\u8072\u660e\uff1a\u672c\u6587\u50c5\u7528\u65bc\u4e00\u822c\u6559\u80b2\uff0c\u4e0d\u80fd\u53d6\u4ee3\u5408\u683c\u81e8\u5e8a\u91ab\u751f\u7684\u5efa\u8b70\u3002\u6cbb\u7642\u6c7a\u5b9a\u61c9\u57fa\u65bc\u500b\u4eba\u7684\u8a3a\u65b7\u3001\u5206\u671f\u3001\u75c5\u7406\u548c\u6574\u9ad4\u5065\u5eb7\u72c0\u6cc1\u3002\u5982\u679c\u60a8\u767c\u73fe\u6301\u7e8c\u6216\u4ee4\u4eba\u64d4\u6182\u7684\u75c7\u72c0\uff0c\u8acb\u5c0b\u6c42\u91ab\u7642\u8a55\u4f30\u3002<\/em><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Myeloproliferative Neoplasms (MPNs) refer to a group of blood cancers characterized by excessive production of blood cells within the bone marrow.<\/p>","protected":false},"featured_media":305,"menu_order":118,"template":"","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-440","cancer_type","type-cancer_type","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/all-cancers.com\/zh-hk\/wp-json\/wp\/v2\/cancer_type\/440","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/all-cancers.com\/zh-hk\/wp-json\/wp\/v2\/cancer_type"}],"about":[{"href":"https:\/\/all-cancers.com\/zh-hk\/wp-json\/wp\/v2\/types\/cancer_type"}],"version-history":[{"count":0,"href":"https:\/\/all-cancers.com\/zh-hk\/wp-json\/wp\/v2\/cancer_type\/440\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/all-cancers.com\/zh-hk\/wp-json\/wp\/v2\/media\/305"}],"wp:attachment":[{"href":"https:\/\/all-cancers.com\/zh-hk\/wp-json\/wp\/v2\/media?parent=440"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}